September 21, 2020 by Todd Huseby, Rodey Wing and Emily Rowe
coronavirus (COVID-19), health care, health care costs, pharmacy benefit manager (PBM)
Pharmacy, September 21, 2020
Today’s retail pharmacies face increasing pressure from all fronts. Governments are aiming to reduce health care costs, and public sentiment is pushing the industry toward a value-based model. The use of high-cost specialty drugs is increasing dispensing complexity and shifting channel volume — at a time when disruptors like Amazon are poised to impact pricing.
February 18, 2019 by Jerry Cacciotti
health care costs
February 18, 2019, Opinion
Editor’s note: The fifth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. America faces skyrocketing health care expenses. The Centers for Medicare and Medicaid Services (CMS) projects that national health spending will grow by 5.6% annually to 2025. The growth in health expenditures is
April 14, 2017 by Chain Drug Review
disease prevention, health care costs, NACDS, National Association of Chain Drug Stores, preventive health care, Preventive Health Savings Act, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores has voiced support of impending legislation that would highlight the value of disease prevention and wellness in lowering health care costs. NACDS said it has joined the Healthcare Leadership Council and other stakeholders in a letter to Congress backing the expected reintroduction of the Preventive
April 27, 2016 by Dan Leonard and Chain Drug Review
Dan Leonard, health care costs, National Pharmaceutical Council, value-based insurance design
Opinion
With the heated rhetoric about Obamacare on the presidential campaign trail, congressional hearings focused on drug costs and news reports about these debates, is it possible for all health care stakeholders to work together to develop solutions for containing costs that ensure patient access to care and appropriate treatments and encourage future innovation? We believe
April 14, 2016 by John Schultz and Chain Drug Review
health care costs, IMS Institute for Healthcare Informatics, Medicines Use and Spending in the U.S., Murray Aitken, prescription drug spending, specialty drug spending, U.S. spending on medicines
2016, Featured Articles, Issue 04-18-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
PARSIPPANY, N.J. — Growth in spending on medicines dipped last year, but that hasn’t eased the challenge of balancing access to drugs and the cost of care in an era of innovative but more expensive treatments, according to the IMS Institute for Healthcare Informatics. For the second year, medication spending climbed by double digits in
February 22, 2016 by Geoff Walden and Chain Drug Review
health care costs, Health Transformation Alliance, HTA
2016, Issue 02-22-2016, Issues, Leading Headlines, News, Pharmacy, Supplier News
NEW YORK — Twenty of the country’s largest corporations, including American Express Co., Coca-Cola Co. and Macy’s Inc., have banded together to rein in employee health care costs. The companies have formed Health Transformation Alliance (HTA) to break with wasteful and inefficient marketplace practices that have resulted in employees paying higher premiums, co-payments and deductibles
September 28, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, health care costs, health care reform, health care spending, J. Samantha Dougherty, Jeffrey Woldt, Laura Miller, National Association of Chain Drug Stores, Pharmaceutical Research and Manufacturers of America, retail pharmacies
2015, Issue 09-28-2015, Issues, Opinion
The major provisions of the Patient Protection and Affordable Care Act have been in effect for almost two years now, enough time to undertake an interim analysis of the controversial law’s impact on the health care system. President Obama and other advocates of the ACA, which since its enactment in March 2010 has withstood two